Comparison of bone metabolic markers between maternal and cord blood.
We studied 41 normal pregnant women and their neonates in order to compare bone metabolism between them. We examined more specific bone formation markers (intact osteocalcin, bone-specific alkaline phosphatase) and a recently developed and more sensitive bone resorption marker (C-telopeptide of type I collagen; CTX) than previously available in maternal and umbilical cord venous blood taken at delivery. The concentrations of all markers of bone turnover, including CTX, in cord serum were significantly higher than those in maternal serum. There was no significant correlation between maternal and cord serum levels for any marker. These results indicate that fetal bone turnover is markedly enhanced compared with maternal bone turnover and is independent of maternal bone metabolism in late pregnancy.
Yamaga
A
A
Yokohama City University School of Medicine, Yokohama, Japan.
Taga
M
M
Hashimoto
S
S
Ota
C
C
D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D001842:Bone and Bones / Q000201:enzymology / Q000378:metabolism*; D003094:Collagen / Q000097:blood*; D024042:Collagen Type I; D005260:Female; D005312:Fetal Blood; D006801:Humans; D007231:Infant, Newborn / Q000097:blood; D015675:Osteocalcin / Q000097:blood*; D010455:Peptides / Q000097:blood*; D011247:Pregnancy / Q000097:blood*
D015415:Biomarkers; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D015675:Osteocalcin; D003094:Collagen; D000469:Alkaline Phosphatase